Article

FDA approves generic equivalent to ophthalmic ointment

The FDA has approved Akorn Inc.'s abbreviated new drug application for neomycin and polymyxin B sulfates, and bacitracin zinc ophthalmic ointment USP, a generic therapeutic equivalent to Monarch Pharmaceuticals' Neosporin ophthalmic ointment.

Related Videos
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
© 2024 MJH Life Sciences

All rights reserved.